Covered recipient · General Payments record
ARBAZ AHMAD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2023–2024
$636.85
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $590.71 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $205.17 | 12 |
| Lilly USA, LLC | $139.91 | 3 |
| ABBVIE INC. | $63.52 | 3 |
| PFIZER INC. | $39.83 | 2 |
| Merck Sharp & Dohme Corporation | $30.64 | 2 |
| IBSA Pharma Inc. | $22.81 | 1 |
| Organon LLC | $20.70 | 1 |
| Phadia US Inc. | $19.40 | 1 |
| Exact Sciences Corporation | $16.93 | 1 |
| Acerta Pharma LLC | $16.85 | 1 |
| Cranial Technologies, Inc | $14.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.45 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106418148 | CMS |
| ABBVIE INC. | $20.10 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106418150 | CMS |
| ABBVIE INC. | $21.97 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106418152 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.85 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104263729 | CMS |
| Cranial Technologies, Inc | $14.95 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082247808 | CMS |
| Exact Sciences Corporation | $16.93 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114570960 | CMS |
| IBSA Pharma Inc. | $22.81 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142981529 | CMS |
| Lilly USA, LLC | $107.21 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135558610 | CMS |
| Lilly USA, LLC | $18.48 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135558608 | CMS |
| Lilly USA, LLC | $14.22 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135536341 | CMS |
| Merck Sharp & Dohme LLC | $14.57 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141941299 | CMS |
| Merck Sharp & Dohme LLC | $16.07 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141754916 | CMS |
| Novo Nordisk Inc | $15.72 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100407442 | CMS |
| Novo Nordisk Inc | $20.71 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100575402 | CMS |
| Novo Nordisk Inc | $7.27 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100399002 | CMS |
| Novo Nordisk Inc | $18.83 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100513813 | CMS |
| Novo Nordisk Inc | $24.69 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100483995 | CMS |
| Novo Nordisk Inc | $22.51 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100296979 | CMS |
| Novo Nordisk Inc | $16.59 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100545852 | CMS |
| Novo Nordisk Inc | $18.14 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100225166 | CMS |
| Novo Nordisk Inc | $16.93 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100622770 | CMS |
| Novo Nordisk Inc | $19.14 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100257558 | CMS |
| Novo Nordisk Inc | $4.44 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100245367 | CMS |
| Novo Nordisk Inc | $20.20 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100280592 | CMS |
| Organon Llc | $20.70 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136214080 | CMS |
| PFIZER INC. | $21.39 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131646795 | CMS |
| PFIZER INC. | $18.44 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131031215 | CMS |
| Phadia US Inc. | $19.40 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067575858 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.